Postdoctoral Research Training in Alzheimer's Disease and Related Neurodegenerative Disorders
阿尔茨海默病和相关神经退行性疾病博士后研究培训
基本信息
- 批准号:10411200
- 负责人:
- 金额:$ 22.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-05-01 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
This is a proposal to renew an advanced postdoctoral training program focused on Alzheimer’s disease and related neurodegenerative disorders at NYU Grossman School of Medicine. There is a critical need to train early career scientists who will investigate Alzheimer’s disease and related neurodegenerative disorders, develop new interventions, and translate these findings from bench to bedside and from bedside to community. The program will continue to be housed in the Center for Cognitive Neurology, an extra-departmental, multidisciplinary program designed to foster collaborative research, with 37 faculty members serving as mentors. The goal of the program is to endow trainees with diverse scientific backgrounds with the necessary skills, multidisciplinary approaches, and rigorous methodologies to advance the field of Alzheimer’s disease and related neurodegenerative disorders. This renewal application expands our current training program by appointing exceptional cognitive neurology clinician-scientist researchers. We will build on our previous training program by appointing three postdoctoral trainees and one cognitive neurology fellow from a well-qualified pool of MD, MD/PhD, and PhD applicants. As per the NIH recommendation for postdoctoral research training, the trainees will be appointed for two years and will continue to receive mentoring and career development support in subsequent years. The program's goals to train these fellows will be accomplished through a tailored curriculum that includes training in rigorous research techniques and quantitative analysis, enhanced mentorship, didactics in foundational concepts, honing science communication skills, and career planning. This training program enables postdoctoral fellows to prepare for the intensely collaborative and interdisciplinary nature of modern research by providing: (a) high-quality scientific training in the area of Alzheimer’s disease and related neurodegenerative disorders, clinical approaches, statistical analyses, and rigorous experimental design; (b) enhanced mentoring that aids trainees’ progress toward future careers in science, and (c) training in the professional skills that are necessary for success in academic research, including critical reading, grant writing, oral presentation, leadership, management, and networking. The training of the next generation of research and clinician scientists with expertise in Alzheimer’s disease and related neurodegenerative disorders is, and will remain, a public health priority in the United States for many years to come. Our collaborative T32 program supports these early scientists as they launch their independent and successful careers in this critical field.
这是一项在纽约大学格罗斯曼医学院更新专注于阿尔茨海默病和相关神经退行性疾病的高级博士后培训计划的提案,迫切需要培训早期职业科学家,他们将研究阿尔茨海默病和相关的神经退行性疾病,开发新的干预措施,并将这些发现从实验室转移到临床,从临床转移到社区。该项目将继续设在认知神经病学中心,这是一个跨部门、多学科的项目,旨在促进合作研究,拥有 37 名教职人员。该计划的目标是为具有不同科学背景的学员提供必要的技能、多学科方法和严格的方法,以推进阿尔茨海默病和相关神经退行性疾病领域的发展。这一更新应用程序通过任命扩大了我们当前的培训计划。我们将在之前的培训计划的基础上,从合格的医学博士、医学博士/博士和博士申请者中任命三名博士后实习生和一名认知神经学研究员。根据美国国立卫生研究院推荐的博士后研究培训,受训者将被任命为两年,并将在随后的几年中继续接受指导和职业发展支持。该计划培训这些研究员的目标将通过量身定制的课程来实现,其中包括严格的研究技术培训。该培训计划通过提供以下内容,使定量博士后研究员能够为现代研究的紧密协作和跨学科性质做好准备:(a)高质量的科学培训。在阿尔茨海默病和相关神经退行性疾病领域、临床方法、统计分析和严格的实验设计;(b) 加强指导,帮助学员在未来的科学职业生涯中取得进展,以及 (c) 必要的专业技能培训学术研究的成功,包括批判性阅读、资助写作、口头报告、领导力、管理和网络,对具有阿尔茨海默病和相关神经退行性疾病专业知识的下一代研究和临床科学家的培训现在和将来都是一个重要的目标。美国公共卫生优先事项在未来的许多年里,我们的合作 T32 计划将为这些早期科学家在这一关键领域开启独立且成功的职业生涯提供支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Helen E Scharfman其他文献
Helen E Scharfman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Helen E Scharfman', 18)}}的其他基金
The Role of Hippocampal area CA2 in Epilepsy
海马区 CA2 在癫痫中的作用
- 批准号:
10745170 - 财政年份:2018
- 资助金额:
$ 22.92万 - 项目类别:
Postdoctoral Research Training in Neurodegenerative Disorders and the Aging Brain
神经退行性疾病和大脑老化的博士后研究培训
- 批准号:
9279591 - 财政年份:2017
- 资助金额:
$ 22.92万 - 项目类别:
Postdoctoral Research Training in Neurodegenerative Disorders and the Aging Brain
神经退行性疾病和大脑老化的博士后研究培训
- 批准号:
10176313 - 财政年份:2017
- 资助金额:
$ 22.92万 - 项目类别:
Postdoctoral Research Training in Alzheimer's Disease and Related Neurodegenerative Disorders
阿尔茨海默病和相关神经退行性疾病博士后研究培训
- 批准号:
10615803 - 财政年份:2017
- 资助金额:
$ 22.92万 - 项目类别:
Diverse Roles of Adult Dentate Gyrus Neurogenesis
成人齿状回神经发生的多种作用
- 批准号:
8668177 - 财政年份:2013
- 资助金额:
$ 22.92万 - 项目类别:
Diverse Roles of Adult Dentate Gyrus Neurogenesis
成人齿状回神经发生的多种作用
- 批准号:
8824981 - 财政年份:2013
- 资助金额:
$ 22.92万 - 项目类别:
相似国自然基金
基于神经退行性疾病前瞻性队列的新烟碱类杀虫剂暴露对阿尔茨海默病的影响及作用机制研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
靶向干预CD33/Aβ相互作用改善小胶质细胞功能延缓AD病理进程
- 批准号:81901072
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
MBP酶切L1CAM介导的线粒体自噬在阿尔茨海默病中的作用和机制
- 批准号:81901296
- 批准年份:2019
- 资助金额:20.5 万元
- 项目类别:青年科学基金项目
游泳训练预防阿尔茨海默病的线粒体机制研究
- 批准号:31871205
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:面上项目
PTENα蛋白在神经退行性疾病中的功能研究
- 批准号:31800849
- 批准年份:2018
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Small Molecule Degraders of Tryptophan 2,3-Dioxygenase Enzyme (TDO) as Novel Treatments for Neurodegenerative Disease
色氨酸 2,3-双加氧酶 (TDO) 的小分子降解剂作为神经退行性疾病的新疗法
- 批准号:
10752555 - 财政年份:2024
- 资助金额:
$ 22.92万 - 项目类别:
Sustained eIF5A hypusination at the core of brain metabolic dysfunction in TDP-43 proteinopathies
持续的 eIF5A 抑制是 TDP-43 蛋白病脑代谢功能障碍的核心
- 批准号:
10557547 - 财政年份:2023
- 资助金额:
$ 22.92万 - 项目类别:
Regulation of microglial function by blood-borne factors
血源性因子对小胶质细胞功能的调节
- 批准号:
10679408 - 财政年份:2023
- 资助金额:
$ 22.92万 - 项目类别:
Effects of Aging on Neuronal Lysosomal Damage Responses Driven by CMT2B-linked Rab7
衰老对 CMT2B 相关 Rab7 驱动的神经元溶酶体损伤反应的影响
- 批准号:
10678789 - 财政年份:2023
- 资助金额:
$ 22.92万 - 项目类别: